Core B- The Developmental (Dev) Core of the San Diego (SD) CFAR aims to support emerging investigators and promote innovative directions in HIV research. The Dev Core provides opportunities for junior investigators and investigators new to HIV research to generate preliminary data for larger grant applications through the awarding of pilot grants (up to $50K for 1 year). Developmental grants are also employed in the recruitment and retention of new HIV research faculty, who can in many cases apply for funding prior to their arrival. Applications are evaluated by the Developmental Grant Review Committee which represents a broad range of HIV research expertise and all four SD CFAR member institutions. In addition, two new categories of grant opportunities available to post-doctoral fellows (Next Generation Grants, up to $10K) and junior faculty with impending NIH R series grant applications (High Impact MicroGrants, up to $3K) are now offered to further leverage CFAR funding to assist these investigators in establishing productive HIV research careers. The Dev Core also collects data on the success of grant awardees in terms of resultant publications, additional grant funding, and career advancement. The Dev Core further cultivates the community of emerging HIV researchers through Training Workshops, seminars and formal mentorship opportunities. These include weekly Work-in-Progress, Journal Club and AIDS Clinical Rounds, mock NIH-style study section reviews for K and R series grant applications (OK Review), and a Leadership Academy where junior faculty are mentored and operate as CFAR Core co- directors. These programs facilitate the academic success of emerging researchers and prepare them for leadership roles. Finally, the Dev Core operates a Rapid Review Board for the efficient solicitation and review of applications for funding opportunities with quick turnaround times, such as certain foundation grants and Administrative Supplements. This Rapid Review Board identifies appropriate mentors for the applicants, provides constructive feedback, and in cases where there are limits on the number of applications, determines which applications are most likely to be successful. With the growth of the SD CFAR, the Dev Core can expand the number of innovative projects and training opportunities that it supports and more effectively cultivate the next generation of talented HIV investigators.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI036214-24
Application #
9537790
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2018-04-01
Budget End
2019-03-31
Support Year
24
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of California, San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Prakash, Katya; Gianella, Sara; Dubé, Karine et al. (2018) Willingness to participate in HIV research at the end of life (EOL). PLoS One 13:e0199670
Fraser, Hannah; Mukandavire, Christinah; Martin, Natasha K et al. (2018) Modelling the impact of a national scale-up of interventions on hepatitis C virus transmission among people who inject drugs in Scotland. Addiction 113:2118-2131
Macal, Monica; Jo, Yeara; Dallari, Simone et al. (2018) Self-Renewal and Toll-like Receptor Signaling Sustain Exhausted Plasmacytoid Dendritic Cells during Chronic Viral Infection. Immunity 48:730-744.e5
Papasavvas, Emmanouil; Lada, Steven M; Joseph, Jocelin et al. (2018) Analytical ART interruption does not irreversibly change pre-interruption levels of cellular HIV. AIDS :
Wertheim, Joel O; Murrell, Ben; Mehta, Sanjay R et al. (2018) Growth of HIV-1 Molecular Transmission Clusters in New York City. J Infect Dis 218:1943-1953
Dubé, Karine; Luter, Stuart; Lesnar, Breanne et al. (2018) Use of 'eradication' in HIV cure-related research: a public health debate. BMC Public Health 18:245
Bengtson, Angela M; Pence, Brian W; Eaton, Ellen F et al. (2018) Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015. Antivir Ther 23:363-372
Dubé, Karine; Gianella, Sara; Concha-Garcia, Susan et al. (2018) Ethical considerations for HIV cure-related research at the end of life. BMC Med Ethics 19:83
Chaillon, Antoine; Gianella, Sara; Lada, Steven M et al. (2018) Size, Composition, and Evolution of HIV DNA Populations during Early Antiretroviral Therapy and Intensification with Maraviroc. J Virol 92:
Letendre, Scott; Bharti, Ajay; Perez-Valero, Ignacio et al. (2018) Higher Anti-Cytomegalovirus Immunoglobulin G Concentrations Are Associated With Worse Neurocognitive Performance During Suppressive Antiretroviral Therapy. Clin Infect Dis 67:770-777

Showing the most recent 10 out of 921 publications